Lu, M., Wu, K., Li, J., Moorman, A. C., Spradling, P. R., Teshale, E. H., . . . Gordon, S. C. (2019). Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure. J Viral Hepat.
Citação norma ChicagoLu, Mei, et al. "Adjuvant Ribavirin and Longer Direct-acting Antiviral Treatment Duration Improve Sustained Virological Response Among Hepatitis C Patients At Risk of Treatment Failure." J Viral Hepat 2019.
Deismireacht MLALu, Mei, et al. "Adjuvant Ribavirin and Longer Direct-acting Antiviral Treatment Duration Improve Sustained Virological Response Among Hepatitis C Patients At Risk of Treatment Failure." J Viral Hepat 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.